Study of Ultomiris® (Ravulizumab) Safety in Pregnancy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy — Stella

Recruiting

Back to Ultomiris-exposed Pregnant/ Postpartum trials

Trial locations(7 sites)

United States

Research Site, Boston, Massachusetts

Australia

Research Site, Melbourne, Victoria

France

Research Site, Paris

Germany

Research Site, Essen, Norte-Westfalia

Italy

Research Site, Rome

Key details

Sponsor

Alexion Pharmaceuticals, Inc.

Enrollment target

~75 participants

Started

December 2024

Primary completion

July 2034

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov